Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Cancer-killing Cells Controlled by Epigenetic… >

Cancer-killing Cells Controlled by Epigenetic Process, New Study Shows

Published: September 24, 2013.
Released by University of Southern California - Health Sciences  

Natural killer (NK) cells in the human body can kill and contain viruses and cancerous tumors, and a new study from the University of Southern California (USC) describes for the first time how those cells can be manipulated by epigenetics. The discovery, detailed in the Proceedings of the National Academy of Sciences, paves the way for developing more effective cancer drugs.

"Natural killer cells are very attractive targets for immunotherapy because they are able to kill tumor cells," said Si-Yi Chen, M.D., Ph.D., a faculty member of the USC Norris Comprehensive Cancer Center and senior author of the study. "While scientists all around the world are working on developing new drugs using NK cells, none of the drugs in development focuses on epigenetic regulation of the cells. Our study describes how an epigenetic process involving the enzyme MYSM1 plays a critical role in the development of natural killer cells."

Epigenetics involve biochemical changes in the body that directly affect DNA, turning some genes on and turning others off. MYSM1 is an enzyme in the body's immune system that turns genes on and off by modifying proteins called histones embedded in DNA.

Through a series of experiments in mice, Chen and his colleagues demonstrate that MYSM1 is required for natural killer cells to mature and function properly.

"We found that MYSM1 creates access to proteins that enhance gene transcription and, ultimately, the maturation of natural killer cells themselves," said Vijayalakshmi Nandakumar, a Ph.D. student at the Keck School of Medicine of USC and the study's first author. "To date, there are no elaborate reports linking an epigenetic phenomenon to natural killer cell development. More importantly, unlike conventional therapies, NK cell-based therapies have shown to be more effective against metastasis. We believe cancer drugs targeting this pathway could be a viable option for future immunotherapies."

The above story is based on materials provided by University of Southern California - Health Sciences.

Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish

comments powered by Disqus

Related »


Immune Cell Discovery Could Help to Halt Cancer Spread
Making Cancer Killers: Reprogramming Immune System Cells to Produce Natural Killer Cells for Cancer
A team of researchers has developed a method to produce cells that kill tumour cells in the lab and …
How to Rescue the Immune System
In a study published in Nature Medicine, Loyola researchers report on a promising new technique that potentially could turn …
Unraveling the Mysteries of the Natural Killer Within Us
Scientists have discovered more about the intricacies of the immune system in a breakthrough that may help combat viral …
Making Cancer Killers
A team of researchers has developed a method to produce cells that kill tumour cells in the lab and …
Why Do Infants Get Sick So Often?
ANN ARBOR, Mich. – Researchers at the University of Michigan Health System are helping to quell parents' worry about …
Scripps Research Institute Study Points to Potential New Therapies for Cancer And Other Diseases
LA JOLLA, CA – November 27, 2012 – Researchers at The Scripps Research Institute (TRSI) are fueling the future …
UGA Study Reveals Flu-fighting Role for Well-known Immune Component
Athens, Ga. – University of Georgia scientists have discovered a new flu-fighting role for a well-known component of the …
La Jolla Institute Identifies Molecular Switch Enabling Immune Cells to Better Fight Disease
SAN DIEGO – (January 20th, 2013) A research team led by the La Jolla Institute for Allergy & Immunology …
More » 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile